Anti-γc and anti-IL-2Rβ mAbs inhibit donor-antigen reactive T cells proliferation and induce H-Y skin graft acceptance in murine model
Bicheng Chen
Abstract
Bicheng Chen
Abstract
Objective The is an To investigate whether blocking common cytokine receptor γ chain (γc) signals can induce transplant tolerance.Methods The animals were randomly divided into 3 groups ( n =7 in each). GroupⅠ (control group): C57BL/6 female mice only received H-Y skin grafts. Group Ⅱ: Female recipients received transfusion of splenocytes (5×10 6 cells) from syngeneic male mice on day 7 before H-Y skin grafting. Group Ⅲ: Following donor-splenocytes pretreatment, on the day 2 and 4, female recipients received intraperitoneal injection of mixture of anti-IL-2Rβ mAb (TM-β1) and anti-γc mAbs (i.e., 4G3, 3E12 and TUGm2, 0.5 mg , respectively). On the day 7, H-Y skin grafts were performed.Results All recipients treated with mixture of mAbs in combination with donor-splenocytes transfusion accepted H-Y skin grafts over 100 days without evidence of rejection. Group Ⅰ rejected grafts within 35 days after grafting (MST= 33.42 days) and group Ⅱ rejected grafts within 17 days after grafting (MST= 14.71 days). There were statistically significant diffe- rences among the groups ( P 0.01 ).Conclusion Blockade of γc signaling in combination with donor- splenocytes pretreatment can markedly prolong H-Y skin graft survival, which might be associated with inhibition of antigen-specific T cell proliferation and induction of apoptosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective The is an To investigate whether blocking common cytokine receptor γ chain (γc) signals can induce transplant tolerance.Methods The animals were randomly divided into 3 groups ( n =7 in each). GroupⅠ (control group): C57BL/6 female mice only received H-Y skin grafts. Group Ⅱ: Female recipients received transfusion of splenocytes (5×10 6 cells) from syngeneic male mice on day 7 before H-Y skin grafting. Group Ⅲ: Following donor-splenocytes pretreatment, on the day 2 and 4, female recipients received intraperitoneal injection of mixture of anti-IL-2Rβ mAb (TM-β1) and anti-γc mAbs (i.e., 4G3, 3E12 and TUGm2, 0.5 mg , respectively). On the day 7, H-Y skin grafts were performed.Results All recipients treated with mixture of mAbs in combination with donor-splenocytes transfusion accepted H-Y skin grafts over 100 days without evidence of rejection. Group Ⅰ rejected grafts within 35 days after grafting (MST= 33.42 days) and group Ⅱ rejected grafts within 17 days after grafting (MST= 14.71 days). There were statistically significant diffe- rences among the groups ( P 0.01 ).Conclusion Blockade of γc signaling in combination with donor- splenocytes pretreatment can markedly prolong H-Y skin graft survival, which might be associated with inhibition of antigen-specific T cell proliferation and induction of apoptosis.
Key concepts: Splenocyte, Skin grafting, Medicine, Monoclonal antibody, Intraperitoneal injection, Immunology, Antigen, Group A